Policy makers and health plans seek value-based management of specialty drugs. This study examines real-world factors that favor some approaches over others and their potential impact. Objectives: ...
The Optimal Care Model reduces waste by empowering physicians with evidence to balance cost and quality in cardiology care. Algorithms help primary care physicians assess coronary artery disease risk, ...
Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes. In the United States, pharmaceutical companies are able to set the ...
About the Author: Ian Chiang is a principal at Flare Capital Partners, a healthcare technology and services-focused VC firm. Prior to joining Flare, he was the SVP of product and innovation and a ...
Forbes contributors publish independent expert analyses and insights. I cover transformation and innovation across the health care industry. For two decades, value-based care has been built upon a ...
Prices for drugs should reflect their value. If price and value become disconnected, efforts to produce new therapies won’t focus on the treatments with the highest net benefit for patients and payers ...
Precision Value Based Management owns the technology that grades and ranks physicians for payers, hospital systems, and ACOs, with over 21 million patients that are being tracked. “They know exactly ...
More than half of health care payments in the US are still based on fee-for-service. Savings attributable to Accountable Care Organizations range from just under 1 percent to just over 6 percent of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results